To view the PDF file, sign up for a MySharenet subscription.

Aspen Pharmacare Holdings Limited - Press Release

Release Date: 07/03/2002 17:08
Code(s): APN
Wrap Text
ASPEN PHARMACARE HOLDINGS LIMITED
Aspen Pharmacare concludes Novartis Agreement

Aspen Pharmacare, Southern Africa's largest generics manufacturer and the largest JSE-listed pharmaceutical company, has concluded a twelve-year product marketing agreement with Novartis South Africa (Pty) Ltd.
The agreement, which is effective from April 1, 2002, makes provision for Aspen Pharmacare to market a basket of Novartis products including Voltaren. ends
Issued by: Shauneen Beukes, Shauneen Beukes Communications Tel & Fax: (012) 661-8467 Cell: 082 389 8900
On Behalf Of: Gus Attridge, Aspen Pharmacare Group Chief Financial Officer Tel: (031) 268 9508 Fax: (031) 208 0170 Cell: 083 628 8813
Jan van Ruymbeke, Novartis South Africa (Pty) Ltd, Executive Director Tel: (011) 929 2542 Fax: (011) 929 2483

Share This Story